Kuhn, Max
PfizerWorldwide R&D,
United States
2025 Rank: 44252
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 135 out of 112089 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 44252 | 50218 |
| Total Cites | 11896 | 12060 |
| H-index | 18 | 19 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 5897 | 5900 |
| Number of Single+First Authored Papers | 3 | 3 |
| Total Cites to Single+First Authored Papers | 10654 | 10666 |
| Number of Single+First+Last Authored Papers | 4 | 4 |
| Total Cites to Single+First+Last Authored Papers | 10681 | 10693 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11393 | 11505 |
| Ratio of Total Citations to Distinct Citing Papers | 1.04 | 1.05 |
| Self-Citation Percentage |
1.36%
|
|
Kuhn, Max
PBC,
United States
2024 Rank: 45204
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 139 out of 105998 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 45204 | 50234 |
| Total Cites | 10214 | 10388 |
| H-index | 19 | 20 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 4699 | 4704 |
| Number of Single+First Authored Papers | 4 | 4 |
| Total Cites to Single+First Authored Papers | 9064 | 9081 |
| Number of Single+First+Last Authored Papers | 5 | 5 |
| Total Cites to Single+First+Last Authored Papers | 9089 | 9106 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9703 | 9823 |
| Ratio of Total Citations to Distinct Citing Papers | 1.05 | 1.06 |
| Self-Citation Percentage |
1.68%
|
|
Kuhn, Max
PBC,
United States
2023 Rank: 52311
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 156 out of 99369 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 52311 | 59526 |
| Total Cites | 8362 | 8532 |
| H-index | 18 | 18 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 3779 | 3784 |
| Number of Single+First Authored Papers | 4 | 4 |
| Total Cites to Single+First Authored Papers | 7302 | 7319 |
| Number of Single+First+Last Authored Papers | 5 | 5 |
| Total Cites to Single+First+Last Authored Papers | 7325 | 7342 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7930 | 8047 |
| Ratio of Total Citations to Distinct Citing Papers | 1.05 | 1.06 |
| Self-Citation Percentage |
1.99%
|
|
Kuhn, Max
PBC,
United States
2022 Rank: 65848
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 198 out of 94672 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 65848 | 73156 |
| Total Cites | 6398 | 6562 |
| H-index | 16 | 17 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 2840 | 2845 |
| Number of Single+First Authored Papers | 4 | 4 |
| Total Cites to Single+First Authored Papers | 5488 | 5505 |
| Number of Single+First+Last Authored Papers | 5 | 5 |
| Total Cites to Single+First+Last Authored Papers | 5505 | 5522 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6036 | 6148 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.07 |
| Self-Citation Percentage |
2.50%
|
|
Kuhn, Max
PBC,
United States
2021 Rank: 70027
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 4782 out of 278898 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 70027 | 78804 |
| Total Cites | 5678 | 5839 |
| H-index | 16 | 16 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 2530 | 2535 |
| Number of Single+First Authored Papers | 4 | 4 |
| Total Cites to Single+First Authored Papers | 4803 | 4820 |
| Number of Single+First+Last Authored Papers | 5 | 5 |
| Total Cites to Single+First+Last Authored Papers | 4819 | 4836 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5355 | 5464 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.07 |
| Self-Citation Percentage |
2.76%
|
|
Kuhn, Max
Pfizer Inc.,
United States
2020 Rank: 121699
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 578 out of 80622 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 121699 | 136581 |
| Total Cites | 3559 | 3695 |
| H-index | 12 | 12 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1562 | 1565 |
| Number of Single+First Authored Papers | 2 | 2 |
| Total Cites to Single+First Authored Papers | 2957 | 2970 |
| Number of Single+First+Last Authored Papers | 3 | 3 |
| Total Cites to Single+First+Last Authored Papers | 2967 | 2980 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3336 | 3423 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.08 |
| Self-Citation Percentage |
3.68%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.